Rangeley Capital LLC Buys Shares of 43,662 SWK Holdings Co. (NASDAQ:SWKH)

Rangeley Capital LLC purchased a new position in shares of SWK Holdings Co. (NASDAQ:SWKH) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 43,662 shares of the company’s stock, valued at approximately $692,000.

A number of other institutional investors have also made changes to their positions in SWKH. Barclays PLC boosted its holdings in SWK by 185.0% during the third quarter. Barclays PLC now owns 4,461 shares of the company’s stock valued at $77,000 after acquiring an additional 2,896 shares during the period. JPMorgan Chase & Co. boosted its stake in SWK by 224.4% during the third quarter. JPMorgan Chase & Co. now owns 6,108 shares of the company’s stock worth $106,000 after buying an additional 4,225 shares in the last quarter. Grace & White Inc. NY raised its position in SWK by 11.1% in the fourth quarter. Grace & White Inc. NY now owns 18,721 shares of the company’s stock worth $297,000 after purchasing an additional 1,871 shares in the last quarter. Finally, SkyView Investment Advisors LLC boosted its position in SWK by 2.1% in the third quarter. SkyView Investment Advisors LLC now owns 31,815 shares of the company’s stock valued at $550,000 after buying an additional 650 shares in the last quarter. 99.27% of the stock is owned by institutional investors.

SWK Price Performance

SWK stock opened at $17.54 on Thursday. The company has a quick ratio of 5.06, a current ratio of 5.06 and a debt-to-equity ratio of 0.11. SWK Holdings Co. has a 12-month low of $15.14 and a 12-month high of $18.09. The stock has a market cap of $214.92 million, a price-to-earnings ratio of 18.86 and a beta of 0.40. The business’s 50-day simple moving average is $16.75 and its 200 day simple moving average is $16.54.

SWK (NASDAQ:SWKH) last announced its earnings results on Wednesday, March 19th. The company reported $0.54 EPS for the quarter, missing the consensus estimate of $0.94 by ($0.40). The company had revenue of $12.36 million for the quarter, compared to analyst estimates of $9.70 million. SWK had a return on equity of 5.07% and a net margin of 26.51%.

About SWK

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.